Effect of tumor CD276 expression on infiltrating immune cells and clinicopathological features of prostate cancer.
Ji LiuAimaitiaji KadierYadong GuoWentao ZhangHaotian ChenZhijin ZhangChangcheng GuoYue ZhangMeiyu BaoJiang GengJunfeng ZhangShiyu MaoXudong YaoPublished in: Prostate cancer and prostatic diseases (2023)
CD276 was found to inhibit the enrichment of CD8+ T cells in PCa. Thus, CD276 inhibitors may be potential targets for immunotherapy.